TerminatedPhase 2

SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

Stopped: Unlikely to demonstrate the intended benefit within the planned study design and statistical framework.

Canada41 participantsStarted 2021-02-23

Plain-language summary

This study will assess the safety and feasibility of sonothrombolysis in the acute management of STEMI undergoing reperfusion therapy with systemic fibrinolysis as part of a pharmacoinvasive approach

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Are expected to receive reperfusion therapy with fibrinolysis
✓. Have a high-risk STEMI ECG as defined as:
✓. Age \>30 years
✓. Adequate apical and/or parasternal images by echocardiography

What they're measuring

Complete ST-Segment Resolution

Timeframe: 90 minutes post TNK administration

Trial details

NCT IDNCT04217304

SponsorUniversity of Alberta

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-19

View on ClinicalTrials.gov More ST Elevation Myocardial Infarction trials